This is similar to the binding mode of donepezil to AChE, and since curcumin is a known antioxidant, we hypothesised that new analogous compounds derived from curcumin should be AChE inhibitors/antioxidant dual-acting compounds that target the multifactorial pathogenic nature of AD.13 The gene discussed is ACHE; the disease is Alzheimer disease.